Hanover Insurance Group Inc. (THG) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hanover Insurance Group I...

    NYSE: THG · Real-Time Price · USD
    177.62
    -3.72 (-2.05%)
    At close: Sep 05, 2025, 3:59 PM
    177.62
    0.00%
    After-hours: Sep 05, 2025, 05:29 PM EDT

    Hanover Insurance Revenue Breakdown

    Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
    Core Commercial Lines Segment Revenue 590.3M 596.6M 576.6M 580M 571M 558.6M 557.1M 556.4M 544.7M 538.9M 527.1M 513.6M 511.1M 522.2M 512.6M 500.4M 493.3M 493.3M 493.3M 456.3M 488.5M 488.7M 483.3M 474.6M 465.2M 459.5M 452.4M
    Core Commercial Lines Segment Revenue Growth -1.06% +3.47% -0.59% +1.58% +2.22% +0.27% +0.13% +2.15% +1.08% +2.24% +2.63% +0.49% -2.13% +1.87% +2.44% +1.44% 0.00% 0.00% +8.11% -6.59% -0.04% +1.12% +1.83% +2.02% +1.24% +1.57% n/a
    Personal Lines Segment Revenue 662.1M 655.7M 644.9M 635.2M 628.4M 627M 620.5M 606.8M 587.8M 578.3M 560.5M 544.2M 530.7M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Personal Lines Segment Revenue Growth +0.98% +1.67% +1.53% +1.08% +0.22% +1.05% +2.26% +3.23% +1.64% +3.18% +3.00% +2.54% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Specialty Lines Segment Revenue 365.2M 363.4M 353.7M 352.8M 342.5M 340.1M 340.9M 340.2M 330.5M 325.5M 319.9M 309.8M 301.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Specialty Lines Segment Revenue Growth +0.50% +2.74% +0.26% +3.01% +0.71% -0.23% +0.21% +2.93% +1.54% +1.75% +3.26% +2.82% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling, General, and Administrative Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist